Illumina analysts expect higher Roche bid
March 29, 2012 at 14:53 PM EDT
lllumina analysts said Thursday that Roche’s latest offer for the genomics blue-chip is still too low and expect the Swiss pharmaceutical giant to eventually sweeten the bid.
